Cargando…
Lung cancer mutation testing: a clinical retesting study of agreement between a real-time PCR and a mass spectrometry test
To investigate the clinical validity and utility of tests for detecting Epidermal Growth Factor Receptor (EGFR) gene mutations in non-squamous non-small cell lung cancer patients, tumour DNA extracts from 532 patients previously tested by the cobas EGFR Mutation Test (RT-PCR test) were retested by t...
Autores principales: | Shepherd, Phillip, Sheath, Karen L., Tin, Sandar Tin, Khwaounjoo, Prashannata, Aye, Phyu S., Li, Angie, Laking, George R., Kingston, Nicola J., Lewis, Christopher A., Mark Elwood, J., Love, Donald R., McKeage, Mark J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5731886/ https://www.ncbi.nlm.nih.gov/pubmed/29254176 http://dx.doi.org/10.18632/oncotarget.21023 |
Ejemplares similares
-
Population-based incidence rates and increased risk of EGFR mutated non-small cell lung cancer in Māori and Pacifica in New Zealand
por: Aye, Phyu Sin, et al.
Publicado: (2021) -
Development and validation of a predictive model for estimating EGFR mutation probabilities in patients with non-squamous non-small cell lung cancer in New Zealand
por: Aye, Phyu Sin, et al.
Publicado: (2020) -
Increasing Disadvantages in Cancer Survival in New Zealand Compared to Australia, between 2000-05 and 2006-10
por: Elwood, J. Mark, et al.
Publicado: (2016) -
Phase I drug-interaction study of effects of calcium and magnesium infusions on oxaliplatin pharmacokinetics and acute neurotoxicity in colorectal cancer patients
por: Han, Catherine H, et al.
Publicado: (2013) -
Predicting effects on oxaliplatin clearance: in vitro, kinetic and clinical studies of calcium- and magnesium-mediated oxaliplatin degradation
por: Han, Catherine H., et al.
Publicado: (2017)